May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Thomas Beaney, Imperial College London
  • ,
  • Louise M. Burrell, University of Melbourne
  • ,
  • Rafael R. Castillo, Adventist Univ Philippines, Coll Med
  • ,
  • Fadi J. Charchar, Federat Univ Australia, Federation University Australia
  • ,
  • Suzie Cro, Imperial College London
  • ,
  • Albertino Damasceno, Eduardo Mondlane Univ, Eduardo Mondlane University, Dept Physiol
  • ,
  • Ruan Kruger, North West University
  • ,
  • Peter M. Nilsson, Lund Univ, Lund University, Skane University Hospital, Dept Hist Med, Skane Univ Hosp
  • ,
  • Dorairaj Prabhakaran, Publ Hlth Fdn India, Public Health Foundation of India, Dept Res & Policy
  • ,
  • Agustin J. Ramirez, Hosp Hosp Univ Fdn Favaloro, Dept Pharmacol & Physiol
  • ,
  • Markus P. Schlaich, Univ Western Australia, Royal Perth Hospital, University of Western Australia, Dobney Hypertens Ctr, Royal Perth Hosp Campus
  • ,
  • Aletta E. Schutte, North West University
  • ,
  • Maciej Tomaszewski, Univ Manchester, University of Manchester, Fac Biol Med & Hlth, Div Cardiovasc Sci
  • ,
  • Rhian Touyz, Cardiovasc Res Ctr, University of Glasgow, Inst Cardiovasc & Med Sci
  • ,
  • Ji-Guang Wang, Shanghai Jiao Tong Univ, Shanghai Jiao Tong University, Dept Hypertens, Rujin Hosp, Sch Med
  • ,
  • Michael A. Weber, State University of New York
  • ,
  • Neil R. Poulter, Imperial College London
  • ,
  • MMM Investigators

Aims Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries.

Methods and results Eighty-nine countries participated in MMM 2018. Volunteers (>= 18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP >= 140 mmHg or diastolic BP >= 90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP >= 140 mmHg or diastolic BP >= 90 mmHg) hypertension.

Conclusion May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk.

OriginalsprogEngelsk
TidsskriftEuropean Heart Journal
Vol/bind40
Nummer25
Sider (fra-til)2006-2017
Antal sider12
ISSN0195-668X
DOI
StatusUdgivet - jul. 2019

Se relationer på Aarhus Universitet Citationsformater

ID: 175251668